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Abstract
Background: Large-scale international projects are underway to generate collections of knockout
mouse mutants and subsequently to perform high throughput phenotype assessments, raising new
challenges for computational researchers due to the complexity and scale of the phenotype data.
Phenotypes can be described using ontologies in two differing methodologies. Traditionally an
individual phenotypic character has either been defined using a single compound term, originating
from a species-specific dedicated phenotype ontology, or alternatively by a combinatorial
annotation, using concepts from a range of disparate ontologies, to define a phenotypic character
as an entity with an associated quality (EQ). Both methods have their merits, which include the
dedicated approach allowing use of community standard terminology, and the combinatorial
approach facilitating cross-species phenotypic statement comparisons. Previously databases have
favoured one approach over another. The EUMODIC project will generate large amounts of
mouse phenotype data, generated as a result of the execution of a set of Standard Operating
Procedures (SOPs) and will implement both ontological approaches to capture the phenotype data
generated.
Results: For all SOPs a four-tier annotation is made: a high-level description of the SOP, to broadly
define the type of data generated by the SOP; individual parameter annotation using the EQ model;
annotation of the qualitative data generated for each mouse; and the annotation of mutant lines
after statistical analysis. The qualitative assessments of phenodeviance are made at the point of data
entry, using child PATO qualities to the parameter quality. To facilitate data querying by scientists
more familiar with single compound terms to describe phenotypes, the mappings between the
Mammalian Phenotype (MP) ontology and the EQ PATO model are exploited to allow querying via
MP terms.
Conclusion: Well-annotated and comparable phenotype databases can be achieved through the
use of ontologically derived comparable phenotypic statements and have been implemented here
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by means of OBO compatible EQ annotations. The implementation we describe also sees scientists
working seamlessly with ontologies through the assessment of qualitative phenotypes in terms of
PATO qualities and the ability to query the database using community-accepted compound MP
terms. This work represents the first time the combinatorial and single-dedicated approaches have
both been implemented to annotate a phenotypic dataset.
Background
The laboratory mouse is widely considered by scientists in
many domains as the primary model organism for the
investigation of human disease. Over the years research
using mouse models has aided the understanding of fun-
damental biological processes as well as playing a major
role in identifying genetic loci involved with disease sus-
ceptibility [1]. A key component to the investigation of
mouse models is the characterisation of their phenotype
and the relationship to the underlying genotype.
The classification and analysis of mouse phenotypes has
been performed in laboratories for many years, in essence
since the beginning of mouse genetics. The majority of
this characterisation would have been on a small number
of mouse models associated with a particular phenotype
or disease model. These mutants would have largely been
from spontaneous mutations arising in mouse laborato-
ries across the world. The number of mutants that can be
generated is greatly increased by using the alkylating agent
N-ethyl N-nitrosourea (ENU), considered one of the most
potent mutagens in mice, which is used to induce point
mutations randomly across the genome. A key switch
from the analysis of a handful of mutants in individual
laboratories or specialised consortiums to the analysis of
a large collection of mutants was therefore the initiation
of ENU mutagenesis programmes [2].
More recently new more elaborate techniques such as
gene targeting and conditional gene trapping have facili-
tated gene driven mutagenesis programmes which aim to
analyse the functions of specific genes and ultimately of
every gene in the mouse genome. Four projects
(EUCOMM http://www.eucomm.org[3], funded by the
European Commission; KOMP http://www.knockout
mouse.org, funded by the National Institutes of Health;
NorCOMM http://norcomm.phenogenomics.ca/
index.htm, funded by GenomeCanada and the TIGM ini-
tiative at the Texas A&M Institute for Genomic Medicine
http://www.tigm.org/) are currently underway to produce
these large collections of mouse mutants [4].
The EUMODIC project (http://www.eumodic.org), which
aims to provide a phenotype assessment of up to 650 of
these knockout lines, was set up as a pilot project for the
large-scale phenotypic assessment of these mutant
resources. The scale and complexity of the data that will be
generated by these projects, together with their analysis
and interpretation, raises new challenges for research in
computation. The two primary computational challenges
arising are the standardised description of the phenotyp-
ing procedure and the rigorous use of ontologies to
describe the data in ways which enable the data to be
accessible to scientists as well as computationally inter-
pretable.
To date, two differing approaches have been adopted to
annotate mouse phenotype data with bio-ontologies.
Either a single dedicated ontology of compound terms
can be employed or an annotation can be built using
terms from a number of distinct ontologies to form a
more complex expression to describe an aspect of an
organism's phenotype [5]. The Mammalian Phenotype
(MP) ontology [6] is an example of a single dedicated
phenotype ontology and the PATO model [7] of defining
phenotypes in terms of an entity (E) which has a quality
(Q) to build EQ annotations is an example of the combi-
natorial approach.
PATO originated as a species neutral ontology of
attributes and values and works in conjunction with spe-
cialised domain ontologies that define the entity under
observation, which can be, for example, an anatomical
structure, a biochemical molecule or a biological process.
Originally, a tripartite structure consisting of an entity +
attribute + value were used to describe an individual phe-
notypic character of an organism, for example 'eye' +
'color' + 'red'. However, PATO has progressed to an ontol-
ogy of phenotypic qualities [8], distinguishing between
qualities which inhere in physical objects and qualities
which inhere in processes. The two hierarchies of
attributes and values have been reconstructed into a single
hierarchy of qualities, so forming bipartite phenotypic
descriptions of 'entity' + 'quality'. So, in keeping with the
previous example, the concept 'red' is now related to
'color' within PATO, using the relationship type is_a.
Therefore, an identical observation to that in the previous
example would be annotated using the EQ structure as
'eye' + 'red'.
The Open Biomedical Ontologies (OBO) family of ontol-
ogies allow for the categorisation of individual terms into
slim families. Slims are cut-down versions of the whole
ontology, containing only a subset of the terms. In theBMC Bioinformatics 2009, 10(Suppl 5):S2 http://www.biomedcentral.com/1471-2105/10/S5/S2
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case of the Gene Ontology (GO) they allow for a broad
overview of the ontology content without the detail of the
finer-grained terms [9], however they also allow for terms
at all levels of specificity within an ontology to be grouped
if they belong to a more specific type. The ability to assign
a PATO concept as an attribute or value has been retained
through the ability to assign a concept membership of the
PATO attribute slim or value slim categories. The mainte-
nance of the attribute and value distinction has facilitated
our application of PATO. PATO's species neutrality lends
itself to the formation of comparable cross-species and
cross-database EQ phenotypic statements. A mouse
kinked tail phenotype can be used as an example to illus-
trate how MP and the PATO model can each be used to
assign an annotation. MP defines this phenotype using
the single term "kinked tail" (MP:0000585) and PATO is
used to assign a quality to the mouse anatomical entity
defined by the Mouse adult gross Anatomy (MA) ontol-
ogy [10] to form the annotation E: tail (MA:0000008) and
Q: kinked (PATO:0001798).
MP has been widely implemented within database
resources with the Mouse Genome Database [11] and the
Rat Genome Database [12] providing associations
between genes and MP terms. However, although recently
used for the description of phenotypes observed during
screens of the tropical freshwater fish, zebrafish [13], there
has, up to now, not been any such comprehensive imple-
mentation of the PATO combinatorial approach within
any mammalian phenotype related informatics resources.
The phenotypic assessment used in EUMODIC consists of
a selection of 22 Standard Operating Procedures (SOPs),
from the European Mouse Phenotyping Resource of
Standardised Screens (EMPReSS, http://
empress.har.mrc.ac.uk) [14,15] organised into two pri-
mary phenotyping pipelines, which consist of a series of
SOPs individually timetabled to be implemented over a
period of seven weeks. The collection of 22 SOPs is
termed EMPReSSslim (http://www.eumodic.org/docu
ments/EMPReSSslim%20pipelines.pdf) and includes a
wide range of procedures collecting phenotype data from
the mouse biological domains of morphology and metab-
olism; cardiovascular system morphology and physiol-
ogy; bone density and morphology; neurobehavioral and
sensory development; haematology and clinical chemis-
try; and allergy and immunity responses. Cohorts of both
mutant and baseline control mice pass through the pipe-
lines.
As a result of carrying out an individual SOP, quantitative
data (e.g. blood pressure measurement), qualitative data
(e.g. coat color description) or a combination of quantita-
tive and qualitative data (e.g. cornea opacity description
and the precise opacity level measurement) can be
returned. This raw phenotyping data on both mutant and
background mouse strains is generated in four mouse
clinics across Europe and the data generated for each
mouse is captured and stored in the EuroPhenome
resource (http://www.europhenome.org)[16]. As men-
tioned previously it is vital that the descriptions of the
SOPs support the unambiguous interpretation and reuse
of the data. To ensure this, all data captured in EuroPhe-
nome conforms to the Minimal Information for Mouse
Phenotyping Procedures (MIMPP) standard and is cap-
tured using its associated XML data format [17].
Our task is to establish how bio-ontologies can be utilised
in this project to ensure that the raw individual mouse
qualitative data captured are standardised and consistent
across the centres and show how quantitative data can be
annotated and analysed with ontologies. Here we present
how we are currently implementing these phenotype
ontologies in this project, issues we have identified, and
how we envisage automatically inferring and annotating
mouse phenotypic ontology terms to mutant lines.
Implementation and results
The ontological annotation and definition of mammalian
phenotype data was undertaken on four levels: the overall
annotation of the SOP's purpose; the annotation of indi-
vidual quantitative measured parameters; the definition
of the qualitative parameters and the allowed results; and
the computational annotation of mutant lines with phe-
notype terms after statistical analysis within EuroPhe-
nome (Figure 1). A distinction is drawn between
qualitative and quantitative phenotype data as the anno-
tation of these two classes of data is handled differently.
Overall annotation of the SOP's purpose
Each EMPReSS SOP has associated with it a list of stand-
ardised parameters that are mesasured through the imple-
mentation of the SOP. The EMPReSSslim SOPs were
annotated using high-level MP terms to give a general
description of the purpose of the procedure and provide a
global summary of all parameters within the SOP (http://
www.eumodic.org/ontology_annotation.html). This
ontological annotation complies with the MIMPP stand-
ard. The assumption is therefore that the resulting MP
annotation of all measured parameters in a SOP will be
children of this high level term. For example, the grip
strength SOP is annotated to the MP term "behavior/neu-
rological phenotype" (MP:0005386) with regard to its
purpose. The grip strength SOP contains two parameters
which involve the measurement of the forelimb grip
strength in isolation in grams, and the measurement of
forelimb and hindlimb grip strength combined in grams
(for further details of this SOP see http://
empress.har.mrc.ac.uk/browser/procedures/
10_10_003_grip_strength_test_d2_1_.pdf). If statisticallyBMC Bioinformatics 2009, 10(Suppl 5):S2 http://www.biomedcentral.com/1471-2105/10/S5/S2
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Levels of ontology annotation of mouse phenotype data Figure 1
Levels of ontology annotation of mouse phenotype data. The relationships between the levels of annotation are shown 
along with real annotations taken from the Hotplate SOP. a) The SOP is annotated using MP. Each parameter, representing a 
mouse trait, is defined using EQ. At the point of annotating individual mouse data, qualitative and quantitative parameters are 
handled differently. Qualitative parameters have a quality assigned to them, with a child-to-parent "is a" relationship to the 
parameter quality, and may be described using MP where a relevant concept exists. Quantitative parameters have a numerical 
value assigned to them. After comparison of the mutant line (cohort of individual mice) to the baseline data, statistically signifi-
cant lines are annotated dynamically. Qualitative EQ data is annotated as being present at an increased or decreased frequency 
and quantitative data annotation using an increased or decreased based EQ statement, where the quality is a child of the 
parameter quality. In both cases, if a relevant MP term exists to define the direct phenotype it is assigned. The annotation of 
inferred phenotypes using MP terms is explained in the Discussion. b) Ontology terms are used to define two Hotplate SOP 
parameters. Example data is used to illustrate possible annotations of the mouse and the mutant strain. The annotations of the 
direct phenotypes allow association with an inferred phenotype.BMC Bioinformatics 2009, 10(Suppl 5):S2 http://www.biomedcentral.com/1471-2105/10/S5/S2
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significant phenotypes were observed for either of these
parameters the mutant line in questions would be anno-
tated to the MP term "abnormal grip strength"
(MP:0001515), which is_a behavior/neurological pheno-
type within MP.
Annotation of individual measured parameters
The directly observed phenotypes identified by individual
measured parameters are defined using the EQ combina-
torial approach in collaboration with scientists with
expert knowledge in each domain. Entities are defined
from a range of OBO Foundry ontologies, including the
Mouse adult gross Anatomy (MA) ontology, Chemical
entities of biological interest (ChEBI) [18] and the biolog-
ical process branch of GO [19]. The PATO qualities used
to define the parameter are members of the PATO
attribute slim category.
Quantitative parameters have a numerical value assigned
to them which are stored in EuroPhenome. After compar-
ison of the mutant line (cohort of individual mice) to the
baseline data, statistically significant lines are annotated
dynamically. This is illustrated in Figure 1.
An overriding factor in the process of annotating parame-
ter definitions, especially while defining parameters for
qualitative data, was making the parameters intuitive to
the phenotyping scientists who would be interacting with
the local Laboratory Information Management System
(LIMS) in mouse clinics. A desirable situation with respect
to data accuracy and consistency would be one where
original LIMS entries could be imported directly into the
EuroPhenome data schema, therefore requiring that non-
informaticians should be able to work seamlessly with
ontologies. Given the large number of entries into the
local LIMS which would be required for a single SOP dur-
ing the lifetime of EUMODIC and the associated time
cost, it was essential that the practical implementation of
ontology terms to define parameters was accessible to
phenotyping scientists. As a result of this process it was
discovered that ontology classes and metadata did not
exist to define anatomical entities using terminology that
was understandable to phenotyping scientists. These
omissions were dealt with by either proposing new terms
for the MA ontology, submission of synonyms of existing
terms or requests for term definitions.
Definition of qualitative data
Qualitative data, for example the data generated from the
implementation of a dysmorphology SOP, require the
objective analysis of data at the point of entry. Qualitative
phenotypes, for example variations in coat colours, are
compared to wild-type mice and the phenotyper respon-
sible for making the comparison must first make the deci-
sion as to whether a mouse is different and if it is, how it
is different. The use of ontologies in capturing qualitative
data at the point of data entry is desirable, since it reduces
the ambiguity associated with interpreting free-text and
the subsequent mapping to an ontological structure. For
this reason the allowed values that could be assigned to a
qualitative parameter were restricted to PATO qualities,
specifically qualities that were child terms to the parame-
ter defining quality and members of the PATO value slim
category. This process, in unison with the definition of
parameters, was carried out in collaboration with pheno-
typing scientists in EUMODIC.
The dysmorphology EMPReSS SOP describes the method
to identify morphological abnormalities and will be used
here as an example of the ontology based definition of
qualitative data. The measured parameters are divided
into 8 observable domains to correspond to the defined
observable areas within the SOP (whole body, coat hair,
skin, head, external genitalia, forelimb, hindlimb, tail).
Each observable domain contains related traits to be
assessed during the SOP. The traits are defined using MA
ontology entities and PATO attribute slim qualities. The
list of possible options for each parameter is given, where
these are child qualities to the parameter qualities (i.e.
PATO value slim qualities) as illustrated in Figure 2. For
each background strain a "wild-type fact sheet" contains
value qualities for each parameter. When phenotyping
mutant mice an assessment of pheno-deviance is made by
making a comparison to the background strain mice.
Only where a mutant phenotype is identified is it
recorded, with all parameters having the value option "as
described for wild-type" set as the default value. This is
structured so that only a single value is submitted for an
individual parameter, so only a single qualitative assess-
ment is made for each parameter. This leads to an exten-
sive list of 181 parameters, which can seem a daunting
task to a phenotyping scientist required to enter the data
for the many mice phenotyped during the EUMODIC
high-throughput screens. However, due to the hierarchi-
cal nature of the parameter list, inherited from the
Directed Acyclic Graph (DAG) structure of the MA ontol-
ogy, which define the entities, an expandable and collaps-
ible hierarchical user interface can be implemented in
local LIMS, whereby value options can be inherited by
parental terms, based on the value submitted for a child
term. For example, an observation of increased eye size (E:
eye, Q: increased size) when recorded in the LIMS would
automatically infer that the parental parameter involving
the qualitative assessment of the head would be recorded
as "abnormal".
Computational annotation of inferred phenotypes
As described above, qualitative mouse phenotypes are
annotated with ontologies, whereas numerical values are
submitted for quantitative mouse parameters, for exam-BMC Bioinformatics 2009, 10(Suppl 5):S2 http://www.biomedcentral.com/1471-2105/10/S5/S2
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ple the concentration of blood haemoglobin, the time
elapsed before the first reaction of a mouse on a hot plate,
or the weight of a mouse heart. A cohort of mice (at least
seven individuals for the purpose of the EUMODIC
screens) each have the same mutation and thus represent
a mutant line. Statistical comparisons of mutant lines
compared to baseline inbred strains are made for all
parameters in EuroPhenome and phenodeviants identi-
fied. Categorical qualitative data and quantitative data are
subject to specialised statistical tests, with for example, the
Chi-squared test used for categorical data and the t-test or
the Mann-Whitney U test used for quantitative data. Phe-
nodeviants, which display significantly different values,
are then objectively annotated with MP and EQ terms
using the parameter annotations described above (Figure
1). The annotation of mutant lines depends on the quali-
tative or quantitative nature of the parameter. Qualitative
parameters are annotated as having the EQ annotation
occurring at a higher or lower frequency compared to the
baseline stain, thus the EQ annotation is itself annotated
as being present at an "increased frequency"
(PATO:0000380) or a "decreased frequency"
(PATO:0000381). Quantitative data is assigned an EQ
annotation after statistical analysis where the quality is a
child to the parameter quality and states an increase or
decrease compared to the baseline strain. Where equiva-
lent MP concepts exist, these are also used to annotate the
direct phenotype. These inferred phenotypes (which may
alter over time as new data enter the databases and sample
sizes change) can be utilised by users of EuroPhenome to
identify mutants of interest and the scientists can then
obtain the raw data to determine from their expert knowl-
edge or future analysis that the inferred phenotype is cor-
rect.
A distinction is made in the annotation of mutant lines
between a direct phenotype and an inferred phenotype. A
direct phenotype is defined as the observable characteris-
tic obtained as a direct result of carrying out the SOP and
retrieving a value for the parameter; using the hot plate
SOP parameter of measuring the time before a first
response as an example, the increased time (in seconds)
for a mutant line to show a reaction compared to the base-
line is a direct phenotype. An inferred phenotype is the
extrapolation of the direct phenotype to infer some bio-
logical meaning. For instance, using the hotplate SOP
example again, it could be inferred that the mutant line
demonstrates an "increased thermal nociceptive thresh-
old" (MP:0001973). This is an inferred phenotype
because the parameter measures a time in seconds and not
Relationship between qualitative parameter and data Figure 2
Relationship between qualitative parameter and data. An example dysmorphology parameter and the corresponding 
value options are shown. The central photo shows a mouse with a sparse distribution of coat hair. A portion of the MA ontol-
ogy is shown on the left and a portion of PATO (Revision 1.118)  is shown on the right (visualised used OBO-Edit [21]). The 
highlighted terms are used to define the coat hair distribution parameter and the resulting phenotype annotation, illustrating 
the relationship between the parameter quality and the phenotype quality.BMC Bioinformatics 2009, 10(Suppl 5):S2 http://www.biomedcentral.com/1471-2105/10/S5/S2
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a behavioural threshold. Although in this case the connec-
tion between direct and inferred phenotype is relatively
intuitive, in other cases it may not be and may depend on
a number of phenotypic characters, represented by indi-
vidual parameters, perhaps from different SOPs, before a
complete phenotype can be inferred. Additionally, there
may be disagreement within the community as to what
biological meaning can be inferred from the results of cer-
tain parameters. For these reasons we make the distinction
between direct and inferred phenotypes, where inferred
phenotypes are currently defined using community recog-
nised MP concepts.
Data querying
Discussions with scientists during this practical ontology
annotation process have revealed that there is a preference
for interacting with the database, at the point of data que-
rying, via community standard compound phenotype
ontology terms where complex qualitative phenotypes are
concerned. It is recognised that for some compound
terms, when deconstructed into EQ format, they may lose
their biological meaning. For example the term "belly
spot" (MP:0000373) is deconstructed to "spotted"
(PATO:0000333)  has_quality  "white" (PATO:0000323)
inheres_in "coat hair" (MA:0000155) part_of "abdomen"
(MA:0000029) (available from the mammalian_phenotype
logical definitions OBO file, OBO Foundry). A solution, as
implemented within EuroPhenome, is to store the pheno-
type in the database in the deconstructed format but allow
entry of the data and subsequent querying via the com-
pound term, so in this example belly spot.
Discussion
As the use of bio-ontologies to define mouse phenotype
observations becomes increasingly commonplace it is
essential that the ontologies are accessible and under-
standable by those scientists who will make use of them
and benefit from their implementation the most. This
demographic is no longer restricted to ontologists or bio-
informaticians, who will continue to play an essential role
in developing and maintaining ontologies, but includes
the "wet-science" researchers who will want to query large
data sets using meaningful ontological terms and relation-
ships in order to find phenotypes of interest. A specific
example taken from the EUMODIC project would be sci-
entists from secondary phenotyping clinics (centres that
carry out more sophisticated phenotyping on lines identi-
fied as phenodeviants from first line screens) who will
want to identify individual mice exhibiting relevant
mutant phenotypes from EuroPhenome which will then
undergo secondary phenotyping procedures. These
researchers will also become increasingly responsible for
entering their data into databases, albeit with appropriate
quality control mechanisms in place, so the descriptive
power of ontologies must be exploited to ensure they are
as scientist friendly as possible.
In our discussions with phenotyping scientists with
regards to interpreting their free-text descriptions of
mouse phenotypes, we have identified a number of omis-
sions of terms from the Mouse Anatomy ontology, for
example nose skin, which were regarded as essential for the
precise categorisation of phenotypes. In other cases exist-
ing terms were not intuitive to scientists and synonyms
were suggested, for example "hind paw" as a synonym of
"foot" (MA:0000044) and "skull" as a synonym of "head
bone" (MA:0000576). Terms were also identified which
required definitions in order to convey any useful mean-
ing, for example "foot digit 1" (MA:0000465) and "hand
digit 4" (MA:0000457). Our suggestions were passed onto
MA curators. It is only through the practical application of
phenotype ontologies that omissions and potential
improvements such as these will be identified.
A desirable advancement of the current ontology annota-
tion framework would include a description of how the
data for a particular parameter was derived experimen-
tally. In order to facilitate this aim, current research is
focused on the development and implementation of an
assay ontology which will provide coherent definitions of
each individual procedural component contained within
a SOP. Work to investigate the benefits associated with
representing the EMPReSS Slim SOPs using the Ontology
of Experimental Actions (EXACT) [20] has begun. EXACT
has been used to define each individual experimental
action within a SOP (Figure 3). The context of a specific
phenotypic EQ annotation can then be defined with the
inclusion of this procedural data into a phenotype data
capture framework as illustrated in Figure 3.
Conclusion
With the advent of large scale mouse phenotyping pro-
grams which aim to phenotype a mouse knockout for
every gene in the mouse genome, automated annotation
with ontologies using a pipeline like the one described
here will be crucial. In comparison to the genome
sequencing projects, automated phenotype annotation
can be curated by experts but an automated method of
identifying the putative phenotype profile of a mouse
mutant quickly is vital to allow users a window into a
large dataset. We have described the ongoing efforts
within the EuroPhenome mouse phenotyping resource to
implement both the MP and the EQ combinatorial
approach to systematically annotate real mouse pheno-
types, derived from community approved SOPs, on a large
scale. The four levels of annotations sees the marrying
together of the two different phenotype annotation
approaches into a framework that facilitates both data
accessibility to mouse scientists using familiar terminol-BMC Bioinformatics 2009, 10(Suppl 5):S2 http://www.biomedcentral.com/1471-2105/10/S5/S2
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ogy and cross-database and cross-species phenotype state-
ment comparisons through the storage of phenotypes in
the EQ format at the database level. The computational
annotation of mouse mutant lines with phenotype ontol-
ogies is key to analysing large databases of raw phenotyp-
ing data. The explosion of this raw phenotyping data will
mean that expert annotation of each mutant will be unfea-
sible. The automated approach allows the annotation to
be refined as new raw data is incorporated into the data-
base. Future interfaces for the querying of EuroPhenome
data will exploit mappings between MP and EQ terms to
accommodate the direct retrieval of EQ annotations in
addition to querying via MP.
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Incorporation of assay data into the annotation framework for an individual mouse Figure 3
Incorporation of assay data into the annotation framework for an individual mouse. A simplified operating proce-
dure is shown marked up using EXACT ontology concepts (left box). The phenotype and procedural data capture framework, 
to describe an instance of tail length, incorporates the experimental action from within the SOP where the phenotype data was 
obtained. Also shown is the relationship of parameter assayed_by SOP returns_value value, which is a child quality of the param-
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